This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$30.34
US$ Class I Dist
NAV per share 21.05.2020
£465.9mAUM

AUM 30.04.2020

Holdings
73.38% Active Share
As at 30.04.2020